Matthew Mefford to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Matthew Mefford has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
1.602
-
Trends in Statin Use Among US Adults With Chronic Kidney Disease, 1999-2014. J Am Heart Assoc. 2019 01 22; 8(2):e010640.
Score: 0.554
-
Willingness to be Reinitiated on a Statin (from the REasons for Geographic and Racial Differences in Stroke Study). Am J Cardiol. 2018 09 01; 122(5):768-774.
Score: 0.530
-
Use of Tenofovir Alafenamide Fumarate for HIV Pre-Exposure Prophylaxis and Incidence of Hypertension and Initiation of Statins. JAMA Netw Open. 2023 09 05; 6(9):e2332968.
Score: 0.191
-
Low-density lipoprotein cholesterol levels among individuals experiencing statin-associated symptoms: Data from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. J Clin Lipidol. 2020 Sep - Oct; 14(5):720-729.
Score: 0.153
-
Association of Region and Hospital and Patient Characteristics With Use of High-Intensity Statins After Myocardial Infarction Among Medicare Beneficiaries. JAMA Cardiol. 2019 09 01; 4(9):865-872.
Score: 0.144
-
Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014. J Am Coll Cardiol. 2017 Jun 06; 69(22):2696-2706.
Score: 0.031